For the Inventor, By the Inventor

Enter assignee name

San Carlos, CA, United States of America

Alkahest, Inc.

USPTO Granted Patents = 29

% Expired Patents = 3.4

CIPO Patents = 2

EPO Patents = 16

Trademarks = 3

Forward Citations = 73

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Steven P Braithwaite (10 out of 13 patents)

Ian Gallager (9 out of 9 patents)

S Sakura Minami (9 out of 9 patents)

4. Viktoria Kheifets (9 out of 16 patents)

5. Eva Czirr (8 out of 8 patents)

6. Benson Lu (7 out of 7 patents)

7. Karoly Nikolich (6 out of 8 patents)

8. Meghan Kerrisk Campbell (5 out of 5 patents)

9. Nina Huber (4 out of 4 patents)

10. Marian Castro (3 out of 3 patents)

11. Sam Jackson (3 out of 3 patents)

12. Balazs Szoke (2 out of 2 patents)

13. Anton Wyss-Coray (2 out of 20 patents)

14. Saul A Villeda (2 out of 6 patents)

15. Joseph McCracken (2 out of 2 patents)

Core Competencies:

Blood Plasma Fractions

Cognitive Disorders

Liver Regeneration

Muscle Regeneration

CCR3 Inhibitors

Leukotriene A4 Hydrolase

Aging-Associated Diseases

Tumor Therapy

Postoperative Recovery

Wound Healing

Pharmaceutical Formulations

Cognitive Impairments

29 patents: Sort by Forward Citations

1. 12758581 - Use of plasma and plasma fractions for improvement of pain, wound healing, and postoperative recovery (2026-10-13),

2. 12697373 - Blood plasma fractions as a treatment for aging-associated cognitive disorders (2026-08-04),

3. 12692301 - Methods of improving retina-associated disease outcome using CCR3-inhibitors (2026-07-28),

4. 12496296 - Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases (2025-12-16),

5. 12059453 - Blood plasma fractions for use in muscle regeneration (2024-08-13),

6. 12053489 - Blood plasma fractions for use in liver regeneration (2024-08-06),

7. 11957671 - Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases (2024-04-16),

8. 11951102 - Methods and compositions for treating retina-associated disease using CCR3-inhibitors (2024-04-09),

9. 11660316 - Methods of inducing liver regeneration by administering a plasma protein fraction (2023-05-30),

10. 11612596 - Pharmaceutical formulations comprising CCR3 antagonists (2023-03-28),

11. 11590118 - Methods and compositions for treating retina-associated disease using CCR3-inhibitors (2023-02-28),

12. 11547724 - Methods of treating a subject for pain (2023-01-10),

13. 11484551 - Method of treating liver failure with plasma fraction IV-4 (2022-11-01),

14. 11439687 - Blood plasma fractions for use in muscle regeneration (2022-09-13),

15. 11426399 - Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase (2022-08-30),

Company Overview

Alkahest, Inc. is a biotechnology company based in San Carlos, California, focused on developing innovative therapies aimed at treating age-related diseases. The organization specializes in harnessing the potential of human plasma and its components to create treatments that target neurodegenerative conditions and other age-associated disorders. By leveraging advanced research in biochemistry and molecular biology, Alkahest aims to improve health outcomes and enhance the quality of life for aging populations.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

29 Patents

#10 in San Carlos, CA

#2,767 in California

#11,625 in US

#22,552 in the World

San Carlos, CA, United States of America

Alkahest, Inc.

Forward Citations = 73

29 inventors:

Steven P Braithwaite (10 out of 13 patents)

Ian Gallager (9 out of 9 patents)

S Sakura Minami (9 out of 9 patents)

4. Viktoria Kheifets (9 out of 16 patents)

5. Eva Czirr (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alkahest, Inc.. Retrieved from https://idiyas.com/company/alkahest

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…